Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh, … , Steven A. Rosenberg, Drew C. Deniger
Parisa Malekzadeh, … , Steven A. Rosenberg, Drew C. Deniger
Published March 1, 2019; First published February 4, 2019
Citation Information: J Clin Invest. 2019;129(3):1109-1114. https://doi.org/10.1172/JCI123791.
View: Text | PDF
Categories: Concise Communication Immunology Oncology

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers

Abstract

Authors

Parisa Malekzadeh, Anna Pasetto, Paul F. Robbins, Maria R. Parkhurst, Biman C. Paria, Li Jia, Jared J. Gartner, Victoria Hill, Zhiya Yu, Nicholas P. Restifo, Abraham Sachs, Eric Tran, Winifred Lo, Robert P.T. Somerville, Steven A. Rosenberg, Drew C. Deniger

×

Full Text PDF | Download (1.72 MB)